Loss of glucocerebrosidase 1 activity causes lysosomal dysfunction and α-synuclein aggregation

참고문헌 (Reference)

1 Schondorf DC, "iPSC-derived neurons from GBA1-associated Parkinson's disease patients show autophagic defects and impaired calcium homeostasis" 5 : 4028-, 2014

2 Bahr BA, "The neuropathogenic contributions of lysosomal dysfunction" 83 : 481-489, 2002

3 Brady RO, "The metabolism of glucocerebrosides. I. purification and properties of a glucocerebroside-cleaving enzyme from spleen tissue" 240 : 39-43, 1965

4 Rosenbloom B, "The incidence of Parkinsonism in patients with type 1Gaucher disease : data from the ICGG Gaucher Registry" 46 : 95-102, 2011

5 Hein LK, "Secondary sphingolipid accumulation in a macrophage model of Gaucher disease" 92 : 336-345, 2007

6 Murphy KE, "Reduced glucocerebrosidase is associated with increased alpha-synuclein in sporadic Parkinson's disease" 137 : 834-848, 2014

7 Butler D, "Potential compensatory responses through autophagic/lysosomal pathways in neurodegenerative diseases" 2 : 234-237, 2006

8 Hoehn MM, "Parkinsonism: onset, progression and mortality" 17 : 427-442, 1967

9 Dauer W, "Parkinson's disease : mechanisms and models" 39 : 889-909, 2003

10 Jang A, "Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions" 113 : 1263-1274, 2010

11 Daher JP, "Neurodegenerative phenotypes in an A53T alpha-synuclein transgenic mouse model are independent of LRRK2" 21 : 2420-2431, 2012

12 Xu YH, "Multiple pathogenic proteins implicated in neuronopathic Gaucher disease mice" 23 : 3943-3957, 2014

13 Sidransky E, "Multicenter analysis of glucocerebrosidase mutations in Parkinson's disease" 361 : 1651-1661, 2009

14 Balducci C, "Lysosomal hydrolases in cerebrospinal fluid from subjects with Parkinson's disease" 22 : 1481-1484, 2007

15 Lee H-J, "Intravesicular localization and exocytosis of alpha-synuclein and its aggregates" 25 : 6016-6024, 2005

16 Cabrera-Salazar MA, "Intracerebroventricular delivery of glucocerebrosidase reduces substrates and increases lifespan in a mouse model of neuronopathic Gaucher disease" 225 : 436-444, 2010

17 Cuervo AM, "Impaired degradation of mutant alpha-synuclein by chaperone-mediated autophagy" 305 : 1292-1295, 2004

18 Orvisky E, "Glucosylsphingosine accumulation in tissues from patients with Gaucher disease: correlation with phenotype and genotype" 76 : 262-270, 2002

19 Yang NY, "Glucocerebrosidase, a new player changing the old rules in Lewy body diseases" 394 : 807-818, 2013

20 Goker-Alpan O, "Glucocerebrosidase is present in alpha-synuclein inclusions in Lewy body disorders" 120 : 641-649, 2010

21 Gegg ME, "Glucocerebrosidase deficiency in substantia nigra of parkinson disease brains" 72 : 455-463, 2012

22 Pankratz N, "Genomewide association study for susceptibility genes contributing to familial Parkinson disease" 124 : 593-605, 2009

23 Simon-Sanchez J, "Genome-wide association study reveals genetic risk underlying Parkinson's disease" 41 : 1308-1312, 2009

24 Satake W, "Genome-wide association study identifies common variants at four loci as genetic risk factors for Parkinson's disease" 41 : 1303-1307, 2009

25 Edwards TL, "Genome-wide association study confirms SNPs in SNCA and the MAPT region as common risk factors for Parkinson disease" 74 : 97-109, 2010

26 Mazzulli JR, "Gaucher disease glucocerebrosidase and alpha-synuclein form a bidirectional pathogenic loop in synucleinopathies" 146 : 37-52, 2011

27 Hruska KS, "Gaucher disease : mutation and polymorphism spectrum in the glucocerebrosidase gene(GBA)" 29 : 567-583, 2008

28 Tsuang D, "GBA mutations increase risk for Lewy body disease with and without Alzheimer disease pathology" 79 : 1944-1950, 2012

29 Lee H-J, "Formation and removal of alphasynuclein aggregates in cells exposed to mitochondrial inhibitors" 277 : 5411-5417, 2002

30 Lee HJ, "Enzyme-linked immunosorbent assays for alpha-synuclein with species and multimeric state specificities" 199 : 249-257, 2011

31 Ron I, "ER retention and degradation as the molecular basis underlying Gaucher disease heterogeneity" 14 : 2387-2398, 2005

32 Meikle PJ, "Diagnosis of lysosomal storage disorders : evaluation of lysosomeassociated membrane protein LAMP-1 as a diagnostic marker" 43 : 1325-1335, 1997

33 Lee H-J, "Clearance of alpha-synuclein oligomeric intermediates via the lysosomal degradation pathway" 24 : 1888-1896, 2004

34 Bendikov-Bar I, "Characterization of the ERAD process of the L444P mutant glucocerebrosidase variant" 46 : 4-10, 2011

35 Parnetti L, "Cerebrospinal fluid beta-glucocerebrosidase activity is reduced in Dementia with Lewy Bodies" 34 : 484-486, 2009

36 Sardi SP, "CNS expression of glucocerebrosidase corrects alpha-synuclein pathology and memory in a mouse model of Gaucher-related synucleinopathy" 108 : 12101-12106, 2011

37 이혜진, "Autophagic failure promotes the exocytosis and intercellular transfer of a-synuclein" 생화학분자생물학회 45 (45): 1-9, 2013

38 Clark LN, "Association of glucocerebrosidase mutations with dementia with lewy bodies" 66 : 578-583, 2009

39 Atrian S, "An evolutionary and structure-based docking model for glucocerebrosidase-saposin C and glucocerebrosidase-substrate interactions-relevance for Gaucher disease" 70 : 882-891, 2008

40 Webb JL, "Alpha-Synuclein is degraded by both autophagy and the proteasome" 278 : 25009-25013, 2003

41 Trinh J, "Advances in the genetics of Parkinson disease" 9 : 445-454, 2013

42 Lieberman RL, "A guided tour of the structural biology of gaucher disease : acid-beta-glucosidase and saposin C" 2011 : 973231-, 2011